Aroa Biosurgery Ltd has released a press release.
June 2025 Quarterly Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Aroa Biosurgery
- FY25 Full Year Results Presentation
- FY25 Appendix 4E and Full Year Results
- AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.
- March 2025 Quarterly Report and Appendix 4C
- December 2024 Quarterly Report and Appendix 4C
Later from Aroa Biosurgery
- First clinical evidence published on AROA's ENIVO™ system for surgical dead space management.
- September 2025 Quarterly Report and Appendix 4C
- Appendix 4D and Half Year Report
- Aroa Biosurgery H1 FY26 Results
- Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery